SCHEMBL25833660

SCHEMBL25833660

N#Cc1ccc(-c2cc(Cl)c(C=O)cn2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 3/20 0.41
CASP1 P29466 1/20 0.41
PPARG P37231 3/20 0.40
KDM1A O60341 1/20 0.39
GABRA1 P14867 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA5 P31644 1/20 0.38
GABRA3 P34903 1/20 0.38
PLAU P00749 1/20 0.38
RIPK1 Q13546 1/20 0.38
SCN2A Q99250 1/20 0.38
SCN10A Q9Y5Y9 1/20 0.38
RHEB Q15382 1/20 0.37
EGLN1 Q9GZT9 1/20 0.36
P2RX7 Q99572 1/20 0.36
MAPKAPK2 P49137 1/20 0.36
KMO O15229 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29267451 0.80 LDHA (0.41) KMO
SCHEMBL27452394 0.75 EP300 (0.39) KDM1ACYP11B1CYP11B2MAOB
SCHEMBL20146809 0.72 MKNK1 (0.52)
SCHEMBL2460782 0.72 TDP1 (0.55) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL20646105 0.72 KDM1A (0.49) CASP1KDM1AGABRA1GABRG2GABRB3
SCHEMBL25377183 0.72 TGFBR1 (0.45) KDM1AMAPKAPK2CYP11B1MAOB
SCHEMBL2009241 0.71 KDM1A (0.53) KDM1AGABRA1GABRG2GABRB3GABRA5
SCHEMBL21101287 0.71 MAPKAPK2 (0.45) GRM5CASP1PPARGKDM1AGABRA1
SCHEMBL6061184 0.69 KDM4E (0.50) GRM5KDM1AP2RX7CYP11B1CYP11B2
SCHEMBL17979362 0.69 TRPA1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. (US) 2024-07-09 US disclosed
WO-2023122780-A9 2-PYRAZOLE ANILINES AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD THE KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO disclosed
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD KU LEUVEN R&D (BE) 2023-09-07 US disclosed
WO-2023122780-A2 2-PYRAZOLE ANILINES AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD THE KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 GRM5 4240/4885CASP1 3161/4885PPARG 125/4885
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 GRM5 4240/4885CASP1 3161/4885PPARG 125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.